BioMaxima S.A. (WSE:BMX)
Poland flag Poland · Delayed Price · Currency is PLN
12.85
-0.10 (-0.77%)
Oct 10, 2025, 5:00 PM CET

BioMaxima Revenue

BioMaxima had revenue of 12.91M PLN in the quarter ending June 30, 2025, with 3.58% growth. This brings the company's revenue in the last twelve months to 57.05M, up 16.48% year-over-year. In the year 2024, BioMaxima had annual revenue of 52.85M with 12.96% growth.

Revenue (ttm)
57.05M
Revenue Growth
+16.48%
P/S Ratio
0.94
Revenue / Employee
452.75K
Employees
126
Market Cap
53.88M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202452.85M6.07M12.96%
Dec 31, 202346.79M-97.08M-67.48%
Dec 31, 2022143.87M64.78M81.91%
Dec 31, 202179.09M17.81M29.06%
Dec 31, 202061.28M30.67M100.19%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Diagnostyka2.17B
NEUCA13.04B
Synektik Spólka Akcyjna623.20M
Voxel560.38M
Celon Pharma206.22M
Selvita373.90M
Ryvu Therapeutics130.10M
Centrum Medyczne ENEL-MED789.78M
Revenue Rankings